As Products Enter Clinic ... Scientists Shown the Door  

Oleh:

Ratner, Mark

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: Nature Biotechnology: The Science and Business of Biotechnology vol. 22 no. 9 (Sep. 2004), page 1059.
Topik: PRODUCTS; products; clinic; scientists

Ketersediaan

Perpustakaan Pusat (Semanggi) Nomor Panggil: NN9.1 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

Oncology company OSI Pharmaceuticals of Melville, NY, announced on August 11, its intention to cut 90 of its UK employees, 18% of its workforce, mostly in research to save US$ 10 - 15 million. Th same month, the company completed the US submission of a new drug application (NDA) for tarceva, for the treatment pf patients with advanced non small cell long cancer. The moves are de rigeur for biotechs these days, in keeping with the larger trend toward focusing resources on clinical development programs that will generate product revenues as rapidly as generate product revenues as rapidly as possible rather than on early stage research...

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali